Exploring novel KDR inhibitors based on pharmaco-informatics methodology. - Wikidata - wikimedia - TriplyDB

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

http://www.wikidata.org/entity/Q34600778

about

Biophysical Characterization of Essential Phosphorylation at the Flexible C-Terminal Region of C-Raf with 14-3-3ζ Protein.Phosphorylation of Translation Initiation Factor 2-Alpha in Leishmania donovani under Stress Is Necessary for Parasite Survival.Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches.Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase.Structural features of falcipain-3 inhibitors: an in silico study.Expedient synthesis of the pentasaccharide repeating unit of the O-antigen of Escherichia coli O86 and its conformational analysis.Deciphering the role of the AT-rich interaction domain and the HMG-box domain of ARID-HMG proteins of Arabidopsis thaliana.

P2860

Q35752270-977EFBEE-0C94-4DC6-A727-6DBC8B2FF96A Q37538574-92B5361B-DACD-430C-AD6A-B44536169C68 Q40715107-4EF14D25-8625-428C-B985-1E23BE829087 Q41854104-E6D00A6A-8520-4B7E-8D77-DE29BAD9F8A7 Q47629095-D196086A-C66D-4DEF-B0FA-748A9C44116A Q50802476-DFEA8CEB-BC7F-4ADD-AE46-E42F11B169FC Q51583551-FB8352CC-609B-45C1-A29D-7E55C4DF2841

P2860

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

http://www.wikidata.org/entity/Q34600778

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@ast

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@en

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@nl

type

label

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@ast

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@en

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@nl

prefLabel

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@ast

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@en

Exploring novel KDR inhibitors based on pharmaco-informatics methodology.

@nl

P1433

Q34600778-C263EC2C-8575-4064-8375-3A937B6779B1

P1476

Q34600778-C41747B9-BDE1-4D4C-8ACC-C3780FBA1415

P2093

Q34600778-0F400B56-7BE4-47A2-A391-84C452848773

Q34600778-52FEDA97-0B0D-4E29-A218-69C0F1264105

Q34600778-7BFFA700-EE7B-4695-8B45-E766569EB362

Q34600778-A0333745-9EDC-4FC5-8F75-01C78BE7D6E4

Q34600778-C5CDF143-9DF1-467F-B934-79A47CE38119

P2860

Q34600778-06E21122-F75E-4C85-AD47-91C30B34FE05

Q34600778-0A3EC064-1F64-49CF-B294-A40FF5E3E23E

Q34600778-116FFD3C-9B20-46BF-AA65-01D9D42D4ED3

Q34600778-1229F4D4-3098-4C3D-B1EF-0DB8A7487E53

Q34600778-2075B83A-B3FC-4E4F-A1E5-B3C4E6EB4AAF

Q34600778-25B2ADA7-7DD4-465C-8AC1-FFC2E6E6B709

Q34600778-348056D5-C513-4467-9F5D-8D0612100C2B

Q34600778-35A3A977-CE1A-44B4-9E36-E31A7DBB538F

Q34600778-3D5B9AD3-ADFD-44A5-B71B-62A41438C0A7

Q34600778-3D8C8E41-C6D3-4077-B9AA-4E01B4DD1256

P304

Q34600778-62AFF49A-AD76-4332-A592-B58A2E5DF94F

P31

Q34600778-F417E304-FB99-4442-8FA7-6CEDF999F6DF

P356

Q34600778-32A96C8D-267F-45BB-9451-49EA40C0E2B1

P433

Q34600778-60790AF9-B979-4D0B-8528-7107A7C53920

P478

Q34600778-6199444B-E9BE-42DA-900C-C37637EF8E91

P50

Q34600778-F8A01F4E-0CDE-41F6-AE2B-884ADD16808E

P577

Q34600778-64E83113-6082-4CE3-BA38-A2E21953F7AE

P698

Q34600778-6C43F283-DC01-4E7B-A284-8D3E970E3C70

P356

1062936X.2013.765912

P1433

SAR and QSAR in Environmental Research

P1476

Exploring novel KDR inhibitors based on pharmaco-informatics methodology

@en

P2093

B R Sahoo

http://www.w3.org/2001/XMLSchema#string

G C Sahoo

http://www.w3.org/2001/XMLSchema#string

P Das

http://www.w3.org/2001/XMLSchema#string

P Suryadevara

http://www.w3.org/2001/XMLSchema#string

R K Kar

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors

All-atom empirical potential for molecular modeling and dynamics studies of proteins

Angiogenesis in cancer and other diseases

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes

Regulation of angiogenesis by hypoxia: role of the HIF system

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.

P304

215-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1062936X.2013.765912

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Manas R. Dikhit

P577

2013-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23437769

http://www.w3.org/2001/XMLSchema#string